Fatty Liver News and Research

Latest Fatty Liver News and Research

Endogenous peptide improves glucose and insulin tolerance and reduces body weight in mice

Treating obese mice with catestatin, a peptide naturally occurring in the body, showed significant improvement in glucose and insulin tolerance and reduced body weight, report University of California San Diego School of Medicine researchers.

7 Feb 2018

New discovery could be key to stopping damage caused by inflammation in many diseases

A discovery by Queensland scientists could be the key to stopping damage caused by uncontrolled inflammation in a range of common diseases including liver disease, Alzheimer's and gout.

7 Feb 2018

UT Southwestern oncologist highlights need to improve liver cancer screening rates

Patients with cirrhosis should be screened regularly for liver cancer, though few are – in part because busy physicians often don't order the screening tests, said UT Southwestern oncologists.

30 Jan 2018

New AASLD guideline focuses on improving diagnosis, treatment of liver cancer and NAFLD

A new Practice Guideline and Practice Guidance in Hepatology will help improve the diagnosis and treatment of patients with liver cancer as well as patients with non-alcoholic fatty liver disease (NAFLD), which can lead to liver cancer and is characterized by the build-up of extra fat in liver cells often due to obesity and diabetes.

27 Jan 2018

Powerful anti-oxidant can stop progression of fatty liver disease in young mice

As obesity continues to rise in the U.S., non-alcoholic fatty liver disease (NAFLD) has become a major public health issue, increasingly leading to cancer and liver transplants.

22 Jan 2018

Scarring of fat tissue in obese people can make weight loss more difficult

The fat of obese people becomes distressed, scarred and inflamed, which can make weight loss more difficult, research at the University of Exeter has found.

12 Jan 2018

Hormone therapy combination may improve metabolism without increasing risk of reproductive cancer

Treating ovariectomized mice with a combination of conjugated estrogens and the drug bazedoxifene triggers the expression of genes that improve metabolism and prevent weight gain - without stimulating the uterus and increasing risks of reproductive cancer, a new study suggests.

22 Dec 2017

New recommendations aim to improve diagnosis of liver disease, prevent unnecessary tests

New recommendations, led by experts at the University of Birmingham, have been published to improve the use of liver blood tests.

20 Dec 2017

Genetics may affect how the body responds to a particular diet

We can add one more thing to the list of traits affected by genetics: how our bodies respond to a particular diet.

1 Dec 2017

Metabolic factors in conjunction with alcohol consumption increase risk of severe liver disease

A new study provides insights into the interaction between alcohol consumption and metabolic factors in predicting severe liver disease in the general population.

22 Nov 2017

Pioneering research project aims to develop better diagnostic tests for NAFLD

A pioneering European research project aims to lead to new diagnostic tests to assess patients with non-alcoholic fatty liver disease (NAFLD) and identify those most at risk for developing severe inflammation and liver scarring.

21 Nov 2017

Synthetic double-stranded RNA may have potential for use as vaccine to prevent liver cancer

Primary liver cancer is now the second leading cause of cancer-related death worldwide, and its incidences and mortality are increasing rapidly in the United Stated. In late stages of the malignancy, there are no effective treatments or drugs.

14 Nov 2017

Chronic liver inflammation promotes cancer by suppressing immunosurveillance, study finds

Chronic inflammation is known to drive many cancers, especially liver cancer. Researchers have long thought that's because inflammation directly affects cancer cells, stimulating their division and protecting them from cell death.

8 Nov 2017

Fat hormone associated with NASH may be effective target for therapeutic intervention

The rising obesity epidemic has brought with it an army of maladies. One, in particular, is threatening to outpace many of the disorders that accompany obesity, in terms of occurrence and severity: nonalcoholic fatty liver disease.

7 Nov 2017

Human exposure to glyphosate has increased significantly over 23 years, research finds

Analyzing samples from a prospective study, University of California San Diego School of Medicine researchers found that human exposure to glyphosate, a chemical widely found in weed killers, has increased approximately 500 percent since the introduction of genetically modified crops.

24 Oct 2017

NAFLD linked to higher cardiovascular risk in women, but not in men

Nonalcoholic fatty liver disease is associated with significantly higher risk of subsequent cardiovascular events in women, but not in men, according to research presented this week at The Liver Meeting -; held by the American Association for the Study of Liver Diseases.

20 Oct 2017

Serum metabolites linked to NAFLD may be heritable, research shows

Serum metabolites associated with nonalcoholic fatty liver disease may be heritable, according to research presented this week at The Liver Meeting - held by the American Association for the Study of Liver Diseases.

20 Oct 2017

Common acid reflux drugs linked to progression of chronic liver disease

Approximately 10 percent of the general population take a proton pump inhibitor (PPI) drug to block stomach acid secretions and relieve symptoms of frequent heartburn, acid reflux and gastroesophageal reflux disease.

10 Oct 2017

Consuming high amounts of sugar could increase heart disease risk in healthy people

Healthy people who consume high levels of sugar are at an increased risk of developing cardiovascular disease.

5 Oct 2017

Study compares long-term metabolic effects of conventional and genetically-modified soybean oil

Researchers at the University of California, Riverside have tested a genetically-modified (GM) soybean oil used in restaurants and found that while it induces less obesity and insulin resistance than conventional soybean oil, its effects on diabetes and fatty liver are similar to those of conventional soybean oil.

4 Oct 2017

Fatty Liver News and Research

Latest Fatty Liver News and Research

Endogenous peptide improves glucose and insulin tolerance and reduces body weight in mice

New discovery could be key to stopping damage caused by inflammation in many diseases

UT Southwestern oncologist highlights need to improve liver cancer screening rates

New AASLD guideline focuses on improving diagnosis, treatment of liver cancer and NAFLD

Powerful anti-oxidant can stop progression of fatty liver disease in young mice

Scarring of fat tissue in obese people can make weight loss more difficult

Hormone therapy combination may improve metabolism without increasing risk of reproductive cancer

New recommendations aim to improve diagnosis of liver disease, prevent unnecessary tests

Genetics may affect how the body responds to a particular diet

Metabolic factors in conjunction with alcohol consumption increase risk of severe liver disease

Pioneering research project aims to develop better diagnostic tests for NAFLD

Synthetic double-stranded RNA may have potential for use as vaccine to prevent liver cancer

Chronic liver inflammation promotes cancer by suppressing immunosurveillance, study finds

Fat hormone associated with NASH may be effective target for therapeutic intervention

Human exposure to glyphosate has increased significantly over 23 years, research finds

NAFLD linked to higher cardiovascular risk in women, but not in men

Serum metabolites linked to NAFLD may be heritable, research shows

Common acid reflux drugs linked to progression of chronic liver disease

Consuming high amounts of sugar could increase heart disease risk in healthy people

Study compares long-term metabolic effects of conventional and genetically-modified soybean oil

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Fatty Liver News and Research

Latest Fatty Liver News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in